Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective Ennio LubranoSilvia ScriffignanoFabio Massimo Perrotta Commentary Open access 10 December 2022 Pages: 301 - 306
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons Nurullah AkkoçCarlos H. ArteagaPhilip J. Mease Review Open access 12 January 2023 Pages: 307 - 327
Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data Wan-Hee YooYoung Mo KangJung-Yoon Choe Original Research Open access 08 December 2022 Pages: 329 - 341
A Streamlined Diagnostic Process Improved the Outcomes of Patients with Adult-Onset Still’s Disease: A Single-Center Retrospective Observational Study Shih-Hsin ChangTeng-Chieh HsuDer-Yuan Chen Original Research Open access 10 December 2022 Pages: 343 - 355
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs Kevin L. WinthropArne YndestadStanley B. Cohen Original Research Open access 17 December 2022 Pages: 357 - 373
Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate Roy FleischmannBoulos HaraouiKristen Lee Original Research Open access 19 December 2022 Pages: 375 - 386
Serious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USA Wen-Nan HuangChing-Yi ChuoLisa Lindsay Original Research Open access 26 December 2022 Pages: 387 - 404
Dynamic Characteristics and Predictive Profile of Glucocorticoids Withdrawal in Rheumatoid Arthritis Patients Commencing Glucocorticoids with csDMARD: A Real-World Experience Wenhui XieHong HuangZhuoli Zhang Original Research Open access 06 January 2023 Pages: 405 - 419
Number of Attending Physicians and Accumulated Organ Damage in Patients with Systemic Lupus Erythematosus: LUNA Registry Cross-Sectional Study Ryo YanaiNobuyuki YajimaKen-ei Sada Original Research Open access 06 January 2023 Pages: 421 - 431
Outcomes Following Adalimumab Bio-originator to Biosimilar Switch—A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries Peter C. TaylorYuri Sanchez GonzalezOliver Howell Original Research Open access 12 January 2023 Pages: 433 - 445
Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study Christopher F. BellJake ChungBernard Rubin Original Research Open access 18 January 2023 Pages: 447 - 462
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies Peter C. TaylorYun-Fei ChenYoshiya Tanaka Original Research Open access 20 January 2023 Pages: 463 - 476
High Usability and Applicability Ratings for the New SmartClic®/ClicWise® Injection Device: Evidence from a Health Care Professional Opinion Study Rieke AltenSimon MossMark Latymer Original Research Open access 22 January 2023 Pages: 477 - 487
PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis Stefan SiebertFrank BehrensLaure Gossec Study Protocol Open access 30 December 2022 Pages: 489 - 505
